Hoffmann-laroche INC.

Active Definitive Contract Awarded Last action

Contract number
HHSO100201600038C
Awardee
Awarding agency
Obligated
$183,844,128

Award facts

Opportunity
  • BARDACBRNBAA16100SOL Solicitation number
Contract value 71% obligated
  • $183,844,127.86 Current, with exercised options
  • $259,844,127.86 Potential, with all options
Completion date 82% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Cost No Fee
Place of performance
Woodland Park, NJ 07424, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00017 · The purpose of this modification is add supplemental funding for 0002 and to updated the period of performance (POP) for clin 0001 to end on 12/31/2028. $8,100,000
Supplemental Agreement for work within scope P00016 · The purpose of this modification is add supplemental funding for clin 0001 & 0002 and to updated the period of performance (POP) for clin 0001 to end on… $13,750,000
Other Administrative Action P00015 $0
Supplemental Agreement for work within scope P00014 · The purpose of this modification is to update cost share amount, extend POP, update SOW, and add supplemental funding to clin 0002. $4,650,709
Supplemental Agreement for work within scope P00013 $29,100,000
Supplemental Agreement for work within scope P00012 · The purpose of this modification is to update cost share amount and add supplemental funding to clin 0002. $3,000,000
Supplemental Agreement for work within scope P00011 · The purpose of this modification is a no cost extension, DE-obligate cancelling funds, update cost share amount, and add supplemental funding to clin 0002. $9,271,311
Supplemental Agreement for work within scope P00010 · The purpose of this modification is the addition of supplemental funding of $2,000,000 to support source data verification, full electronic medical record… $2,000,000
Supplemental Agreement for work within scope P00009 $0
Supplemental Agreement for work within scope P00008 · The purpose of this modification is to DE-obligate excess and cancelling funds -$2,352,495
Supplemental Agreement for work within scope P00007 · The purpose of this modification/amendment is to do the following clin 0002 modifications: the addition of the FG-lpxc lung program to clin 0002. The program is… $0
Supplemental Agreement for work within scope P00006 $3,160,549
Other Administrative Action P00005 · The purpose of this modification is to: (1) update the other transaction agreements officer (otao); (2) delete attachment 1, statement of work, dated… $0
Other Administrative Action P00004 · The purpose of modification 0004 is to (1) revise the period of performance; (2) revise the recipient cost share budget and (3) revise attachment 4 (roche barda… $0
Other Administrative Action P00003 · The purpose of modification 0003 is to (1) revise the period of performance; (2) revise the pocs and (3) change the POC for payments. $0
Supplemental Agreement for work within scope 2 · Modification 0002 $0
Change Order 1 · Purpose: the modification 0001 serves seven purposes: (1) in article II(a) term of this agreement: extend the clin 0001 period of performance at no additional… $77,991,877
Original award $35,172,177
Show all 18

About this award

Written by GovTribe AI ·

The Office of the Assistant Secretary for Preparedness and Response awarded a definitive contract to Hoffmann-La Roche Inc. for combating multi-drug resistance and addressing emerging bacterial threats through discovery and clinical development on September 15, 2016, with a ceiling value of $259.8 million.

The contract operates under cost-no-fee pricing with no set-aside. Place of performance is Woodland Park, New Jersey. The period of performance for the base effort (CLIN 0001) extends through December 31, 2028, and the most recent modification added supplemental funding for CLIN 0002 and updated that base period.

In fiscal year 2024, the contract invoiced $35.6 million across 3.8 FTEs and 7,946 contractor hours, yielding a derived government-paid hourly rate of $4,484.73. The awardee self-performed all reported hours with no subcontractors. Invoiced activity in FY2021 totaled $7.1 million.

Quick answers

Who was awarded contract HHSO100201600038C?

HHSO100201600038C was awarded to Hoffmann-La Roche Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 15, 2016.

How much is contract HHSO100201600038C worth?

The government has obligated $183,844,128 on HHSO100201600038C. Its potential value, with all options, is $259,844,128.

Was contract HHSO100201600038C competed?

The extent of competition for HHSO100201600038C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login